{
    "2021-06-04": [
        [
            {
                "time": "",
                "original_text": "沃森生物(300142.SZ)：部分董事、高管向成都喜云转让137.5万股",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "董事",
                        "高管",
                        "成都喜云",
                        "转让"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "沃森生物(300142.SZ)：成都喜云持股数量增至1460.67万股",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "成都喜云",
                        "持股增加"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "沃森生物今日大宗交易成交154万股，成交价64.33元折价0.4%",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "大宗交易",
                        "成交",
                        "折价"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "“植物王国”孕育医疗良企 昆明医企董秘均薪147.6万",
                "features": {
                    "keywords": [
                        "植物王国",
                        "医疗企业",
                        "昆明",
                        "董秘薪资"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "沃森生物大跌 连续下跌",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "大跌",
                        "连续下跌"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "沃森生物盘中快速下跌",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "盘中",
                        "快速下跌"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业2021年1-4月疫苗批签发数据跟踪：二类疫苗维持增长 国产大品种表现良好",
                "features": {
                    "keywords": [
                        "医药生物",
                        "疫苗",
                        "批签发",
                        "二类疫苗",
                        "国产大品种"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2021-06-03",
                "original_text": "A股融资融券日报：两融余额减少4.5亿元（6月3日）",
                "features": {
                    "keywords": [
                        "A股",
                        "融资融券",
                        "两融余额",
                        "减少"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "市场整体"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "2021年医药生物行业半年度策略报告：乘风破浪会有时 辅助生殖新机遇",
                "features": {
                    "keywords": [
                        "医药生物",
                        "半年度策略",
                        "辅助生殖",
                        "新机遇"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "杠杆资金加码成长主线，两市融资余额创近6年新高",
                "features": {
                    "keywords": [
                        "杠杆资金",
                        "成长主线",
                        "融资余额",
                        "新高"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "市场整体"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}